GPT-Rosalind (OpenAI) vs Microsoft MAI-Transcribe-1

Which one should you pick? Here's the full breakdown.

GPT-Rosalind (OpenAI)

C
6.8/10

OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)

Our Pick

Microsoft MAI-Transcribe-1

B
7.9/10

Microsoft's first in-house speech-recognition model -- launched 2026-04-02. #1 on FLEURS WER overall, #1 by FLEURS WER in 11 of the top 25 global languages. Beats Whisper-large-v3, Scribe v2, GPT-Transcribe, Gemini 3.1 Flash-Lite. $0.36/hour of audio on Azure Foundry

CategoryGPT-Rosalind (OpenAI)Microsoft MAI-Transcribe-1
Ease of Use3.06.0
Output Quality9.09.5
Value7.09.0
Features8.07.0
Overall6.87.9

Pricing Comparison

FeatureGPT-Rosalind (OpenAI)Microsoft MAI-Transcribe-1
Free TierNoYes
Starting PriceInvite only$0.36

Which Should You Pick?

Pick GPT-Rosalind (OpenAI) if...

  • More features (8 vs 7)

Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.

Visit GPT-Rosalind (OpenAI)

Pick Microsoft MAI-Transcribe-1 if...

  • Easier to use (6 vs 3)
  • Better value for money (9/10)
  • Has a free tier

Developers and enterprises who need best-in-class multilingual speech-to-text for high-volume use cases (meeting recording pipelines, call-center transcription, accessibility captioning at scale, multilingual audio indexing). Especially relevant for Azure shops already on Microsoft infrastructure.

Visit Microsoft MAI-Transcribe-1

Our Verdict

Microsoft MAI-Transcribe-1 is the clear winner here with 7.9/10 vs 6.8/10. GPT-Rosalind (OpenAI) isn't bad, but Microsoft MAI-Transcribe-1 outperforms it across the board. Pick GPT-Rosalind (OpenAI) only if researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access.